Naga Chalasani Selected Research

Naga Chalasani Research Topics

Disease

77	Non-alcoholic Fatty Liver Disease 01/2022 - 03/2003
72	Fibrosis (Cirrhosis) 11/2022 - 05/2001
43	Liver Diseases (Liver Disease) 01/2022 - 05/2002
34	Chemical and Drug Induced Liver Injury 04/2022 - 01/2009
18	Inflammation (Inflammations) 11/2022 - 05/2008
14	Insulin Resistance 10/2021 - 03/2003
11	End Stage Liver Disease 01/2022 - 08/2015
10	Hepatitis 01/2022 - 07/2007
10	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 01/2013
10	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 06/2006
9	Hemorrhage 12/2020 - 03/2003
9	Alcoholic Fatty Liver 01/2020 - 10/2003
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2019 - 11/2004
8	Obesity 02/2022 - 12/2003
8	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 05/2010
8	Fatty Liver 01/2018 - 04/2005
7	Neoplasms (Cancer) 01/2020 - 07/2013
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2017
6	Infections 01/2021 - 04/2004
5	Jaundice (Icterus) 04/2022 - 03/2007
5	Liver Failure 01/2022 - 06/2008
5	Ascites 01/2022 - 05/2001
5	Body Weight (Weight, Body) 01/2021 - 12/2003
5	Esophageal and Gastric Varices (Esophageal Varices) 01/2020 - 12/2005
4	Weight Gain 02/2022 - 07/2009
4	Alcoholic Hepatitis 11/2021 - 09/2017
4	Weight Loss (Weight Reduction) 09/2015 - 08/2004
4	Hyperlipidemias (Hyperlipidemia) 08/2014 - 12/2003
4	Hepatitis C 02/2012 - 11/2004
3	Acute-On-Chronic Liver Failure 01/2022 - 01/2019
3	Dyslipidemias (Dyslipidemia) 10/2021 - 02/2012
3	Varicose Veins (Varicose Vein) 01/2021 - 07/2007

Drug/Important Bio-Agent (IBA)

21	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
15	Alanine Transaminase (SGPT)IBA 01/2022 - 03/2005
14	Dyphylline (Diprophylline)FDA Link 01/2022 - 01/2009
14	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2010
10	Triglycerides (Triacylglycerol)IBA 10/2021 - 03/2003
9	LipidsIBA 11/2021 - 03/2003
8	Vitamin E FDA LinkGeneric 12/2021 - 05/2010
8	BilirubinIBA 01/2021 - 07/2004
8	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 05/2007
8	EnzymesIBA 04/2020 - 02/2002
7	nasIBA 01/2022 - 01/2011
7	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 04/2011
7	Transaminases (Aminotransferases)IBA 03/2021 - 12/2003
7	Insulin (Novolin)FDA Link 01/2021 - 03/2003
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2014 - 04/2005
6	AlbuminsIBA 01/2022 - 05/2001
6	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 03/2003
6	CytokinesIBA 01/2020 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2006
5	Alkaline PhosphataseIBA 01/2022 - 09/2010
5	Lipoproteins (Lipoprotein)IBA 11/2021 - 02/2012
5	oxidized low density lipoproteinIBA 03/2021 - 08/2004
5	obeticholic acidIBA 01/2020 - 03/2015
5	Biological ProductsIBA 01/2018 - 07/2007
4	Anticonvulsants (Antiepileptic Drugs)IBA 04/2022 - 12/2006
4	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2015
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2007
4	HDL LipoproteinsIBA 11/2021 - 03/2003
4	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2006
4	CholesterolIBA 01/2020 - 02/2012
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2014 - 03/2007
3	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2013
3	Pioglitazone (Actos)FDA Link 05/2021 - 05/2010
3	LDL CholesterolIBA 03/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2021 - 06/2006
3	AutoantibodiesIBA 11/2020 - 01/2012
3	SteroidsIBA 02/2020 - 02/2008
3	Minocycline (Cyclops)FDA LinkGeneric 02/2020 - 01/2017
3	LigandsIBA 12/2019 - 03/2015
3	LDL Lipoproteins (beta Lipoproteins)IBA 10/2019 - 02/2012
3	K-18 conjugate (K18)IBA 01/2019 - 12/2014
3	Hormones (Hormone)IBA 03/2018 - 03/2005
3	InterferonsIBA 01/2018 - 04/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2004
3	Azithromycin (Zithromax)FDA LinkGeneric 11/2015 - 02/2015
3	FructoseIBA 01/2015 - 07/2009
3	Serum AlbuminIBA 07/2014 - 05/2001
3	Cytochrome P-450 CYP3AIBA 01/2013 - 03/2007
3	Vitamin D FDA LinkGeneric 10/2012 - 07/2011
3	IronIBA 01/2012 - 03/2005
3	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 10/2011 - 03/2003
2	Phospholipases (Phospholipase)IBA 11/2022 - 01/2021
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022 - 11/2019
2	AdiponectinIBA 10/2021 - 03/2005
2	procollagen Type III-N-terminal peptide (PIIP)IBA 05/2021 - 01/2021
2	Collagen Type III (Type III Collagen)IBA 05/2021 - 01/2021

Therapy/Procedure

29	Liver Transplantation 02/2022 - 05/2002
27	Therapeutics 08/2020 - 02/2002
6	Bariatric Surgery 01/2022 - 08/2004
5	Transplantation 02/2022 - 05/2002
5	Length of Stay 01/2022 - 08/2015
5	Patient Readmission 01/2022 - 03/2011
4	Ligation 12/2020 - 12/2003
3	Drug Therapy (Chemotherapy) 08/2015 - 05/2002
3	Transjugular Intrahepatic Portasystemic Shunt 08/2011 - 12/2003
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2005 - 03/2003
2	Contraindications 02/2022 - 12/2005
2	Palliative Care (Palliative Therapy) 01/2022 - 01/2020